Dr. Opie is a cannabis ninja, science geek, and serial entrepreneur. He has co-founded and operated 5 laboratories in different verticals including R&D, clinical diagnostics, and cannabis safety testing. His ventures have all been privately held and performed regulated, high-complexity testing. His contribution to successful laboratory operations include business planning, laboratory design and construction, obtaining licenses and accreditations, leading a culture of quality and compliance, technology assessment & selection, assay design & validation, reimbursement strategy, recruitment and staffing, and extensive content marketing.
Dr. Opie is a lifelong educator and has held several adjunct faculty appointments at nationally recognized universities. He recently finished 2 years as an invited Entrepreneurship Expert at the W.P. Carey School of Business at Arizona State University to advise student and faculty entrepreneurs about business planning, financial modeling, pre-revenue venture funding, venture development and growth strategies. He is currently a participating member of the AOAC International - Cannabis Analytical Science Program, and a frequent lecturer on the cannabis industry. Dr. Opie is an invited editor for a textbook being printed and distributed by the global publisher, Springer Nature, in Q4 2020 titled, “Cannabis Laboratory Fundamentals”.
Cannabis laboratory testing is done for human safety. Common cannabis contaminants that have known health risks include pesticides, heavy metals, residual solvents, mycotoxins, and microbial pathogens. It is essential for a fledgling industry seeking credibility to have access to rapid, accurate, and reliable testing so contaminated products can be removed from the supply chain before a sale and so marijuana producers can identify areas to improve their processes.
This presentation will discuss:
- Common cannabis contaminants and the potential health risks of consuming contaminated products
- How to obtain and communicate the value of a cannabis laboratory safety report to buyers
- How predicted changes in testing regulations might affect both consumers and stakeholders in the cannabis supply chain.